Jennison Associates
STRO icon

Jennison Associates’s Sutro Biopharma STRO Stock Holding History

Jennison Associates’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-14,431
Closed -$1.31M – 667
2019
Q3 		$1.31M Sell
14,431
-1,456
-9% -$147K ﹤0.01% 521
2019
Q2 		$1.81M Buy
15,887
+2,108
+15% +$232K ﹤0.01% 505
2019
Q1 		$1.57M Buy
13,779
+474
+4% +$49.3K ﹤0.01% 505
2018
Q4 		$1.2M Sell
13,305
-1,695
-11% -$205K ﹤0.01% 532
2018
Q3 		$2.25M Buy
+15,000
New +$2.27M ﹤0.01% 517

Other funds holding STRO

SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
VM
VV Manager Boston, Massachusetts $114M AUM 59.16% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $718M AUM 8.19% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return